hypopharyngeal cancer, metastatic uveal melanoma and acute lymphoblastic leukemia. It is administered intravenously and intralesionally. The drug candidate is a fully human hinge-stabilized IgG4P ...

Background: Hypopharyngeal cancer (HC) comprises less than 5% of all malignant tumors in the head and neck. They often present at an advanced stage, thereby resulting in high mortalities. We aimed to ...

Internal Jugular Vein (IJV) thrombosis is a potentially lifethreating disease and can occur at any anatomical level. Patients with head and neck cancer are at high-risk category for IJV thrombosis, ...

Surzebiclimab is under clinical development by BeiGene and currently in Phase II for Hypopharyngeal Cancer. According to GlobalData, Phase II drugs for Hypopharyngeal Cancer does not have sufficient ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://mc.manuscriptcentral ...